2,861 reports of this reaction
1.4% of all TOPIRAMATE reports
#17 most reported adverse reaction
PARAESTHESIA is the #17 most commonly reported adverse reaction for TOPIRAMATE, manufactured by Janssen Pharmaceuticals, Inc.. There are 2,861 FDA adverse event reports linking TOPIRAMATE to PARAESTHESIA. This represents approximately 1.4% of all 203,737 adverse event reports for this drug.
TOPIRAMATE has an overall safety score of 85 out of 100. Patients taking TOPIRAMATE who experience paraesthesia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PARAESTHESIA is a less commonly reported adverse event for TOPIRAMATE, but still significant enough to appear in the safety profile.
In addition to paraesthesia, the following adverse reactions have been reported for TOPIRAMATE:
The following drugs have also been linked to paraesthesia in FDA adverse event reports:
PARAESTHESIA has been reported as an adverse event in 2,861 FDA reports for TOPIRAMATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PARAESTHESIA accounts for approximately 1.4% of all adverse event reports for TOPIRAMATE, making it a notable side effect.
If you experience paraesthesia while taking TOPIRAMATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.